| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.23 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.002 |